General description
Daclatasvir is a NS5A direct-acting antiviral agent used in the treatment of chronic hepatitis C virus (HCV) infection.
INN
Daclatasvir
ATC codes
Medicine type
Chemical agent
EML status history
First added in 2015
(TRS
994)
for
Chronic hepatitis C
Wikipedia
DrugBank
Recommendations
Section
Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations
- Oral > Solid: 30 mg tablet (as hydrochloride); 60 mg tablet (as hydrochloride)
Indications